Review: taking Klonopin and Ondansetron together


Summary

Drug interactions are reported among people who take Klonopin and Ondansetron together. This review analyzes the effectiveness and drug interactions between Klonopin and Ondansetron. It is created by eHealthMe based on reports of 1,204 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Klonopin and Ondansetron >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Klonopin

Klonopin has active ingredients of clonazepam. It is often used in stress and anxiety. (latest outcomes from Klonopin 30,926 users)

Ondansetron

Ondansetron has active ingredients of ondansetron. It is often used in nausea. (latest outcomes from Ondansetron 15,492 users)

On Jul, 19, 2016

1,204 people who take Klonopin, Ondansetron are studied.


Number of reports submitted per year:

Klonopin and Ondansetron drug interactions.

Drug effectiveness over time:

Klonopin:
  • < 1 month: 100.0% - (1 of 1 people)
  • 1 - 6 months: 100.0% - (1 of 1 people)
  • 6 - 12 months: 100.0% - (3 of 3 people)
  • 1 - 2 years: 42.0% - (3 of 7 people)
  • 2 - 5 years: 50.0% - (5 of 10 people)
  • 5 - 10 years: 28.0% - (2 of 7 people)
  • 10+ years: 100.0% - (4 of 4 people)
  • not specified: 0.0% - (0 of 0 people)
Ondansetron:
  • < 1 month: 50.0% - (1 of 2 people)
  • 1 - 6 months: 0.0% - (0 of 3 people)
  • 6 - 12 months: 37.0% - (3 of 8 people)
  • 1 - 2 years: 60.0% - (3 of 5 people)
  • 2 - 5 years: 50.0% - (6 of 12 people)
  • 5 - 10 years: 100.0% - (2 of 2 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Klonopin:
  • female: 56.0% - (17 of 30 people)
  • male: 66.0% - (2 of 3 people)
Ondansetron:
  • female: 44.0% - (13 of 29 people)
  • male: 66.0% - (2 of 3 people)

Drug effectiveness by age:

Klonopin:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 1 people)
  • 20-29: 66.0% - (4 of 6 people)
  • 30-39: 50.0% - (4 of 8 people)
  • 40-49: 72.0% - (8 of 11 people)
  • 50-59: 66.0% - (2 of 3 people)
  • 60+: 25.0% - (1 of 4 people)
Ondansetron:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 1 people)
  • 20-29: 20.0% - (1 of 5 people)
  • 30-39: 62.0% - (5 of 8 people)
  • 40-49: 45.0% - (5 of 11 people)
  • 50-59: 33.0% - (1 of 3 people)
  • 60+: 75.0% - (3 of 4 people)

Most common drug interactions over time *:

< 1 month:
  • rash
  • acute respiratory distress syndrome
  • stevens-johnson syndrome
  • arrhythmia
  • myocardial infarction
  • renal impairment
  • blister
  • excoriation
  • gastrointestinal haemorrhage
  • hepatic function abnormal
1 - 6 months:
  • fatigue
  • ileus
  • post procedural haemorrhage
  • renal failure acute
  • thrombocytopenia
  • mucous membrane disorder
  • pruritus
  • rash maculo-papular
  • skin disorder
  • toxic epidermal necrolysis
6 - 12 months:
  • back injury
  • insomnia
  • adenocarcinoma
  • chemotherapy
  • colitis
  • constipation
  • esophageal spasm
  • esophageal stricture - benign
  • gastroparesis
  • intervertebral disc protrusion
1 - 2 years:
  • depression
  • emotional distress
  • hypersexuality
  • obsessive-compulsive personality disorder
  • pathological gambling
  • suicidal ideation
  • foetal exposure during pregnancy
  • adverse reaction
  • drowsiness
  • flatulence
2 - 5 years:
  • diabetic gastroparesis
  • cholecystitis chronic
  • pain
  • pancreatitis
  • gallbladder disorder
  • sphincter of oddi dysfunction
  • arthritis
  • back injury
  • constipation
  • constipation aggravated
5 - 10 years:
  • haematocrit decreased
  • haemoglobin decreased
  • orthostatic hypotension
  • pain in extremity
  • platelet count decreased
  • dizziness
  • dehydration
  • diarrhoea
  • hypotension
  • neutropenia
10+ years:
  • cancer pain
  • constipation
  • headache
  • narcolepsy
  • serotonin syndrome
not specified:
  • anxiety
  • pain
  • nausea
  • dyspnoea
  • chest pain
  • back pain
  • abdominal pain
  • asthenia
  • abdominal pain upper
  • vomiting

Most common drug interactions by gender *:

female:
  • anxiety
  • pain
  • nausea
  • chest pain
  • dyspnoea
  • back pain
  • abdominal pain
  • abdominal pain upper
  • asthenia
  • hypotension
male:
  • anxiety
  • dyspnoea
  • pneumonia
  • pain
  • anaemia
  • nausea
  • confusional state
  • pyrexia
  • sepsis
  • general physical health deterioration

Most common drug interactions by age *:

0-1:
  • convulsion
  • hypertonia
  • agitation neonatal
  • antithrombin iii decreased
  • ascites
  • blood product transfusion dependent
  • cholestasis
  • feeling jittery
  • haemoglobin decreased
  • hepatomegaly
2-9:
  • abnormal behaviour
  • convulsion
  • drug level below therapeutic
  • abdominal pain
  • confusional state
  • muscle tightness
  • febrile bone marrow aplasia
  • mucosal inflammation
  • pulmonary haemorrhage
  • respiratory failure
10-19:
  • pancreatitis
  • cholecystitis chronic
  • oxygen saturation decreased
  • vomiting
  • weight decreased
  • pain
  • international normalised ratio increased
  • restlessness
  • cholelithiasis
  • activated partial thromboplastin time prolonged
20-29:
  • nausea
  • vomiting
  • bronchitis
  • insomnia
  • sinusitis
  • dyspnoea
  • fatigue
  • upper respiratory tract infection
  • headache
  • urinary tract infection
30-39:
  • pain
  • nausea
  • anxiety
  • chest pain
  • dyspnoea
  • fatigue
  • asthenia
  • headache
  • convulsion
  • neutropenia
40-49:
  • abdominal pain
  • anxiety
  • chest pain
  • back pain
  • hypotension
  • abdominal pain upper
  • respiratory failure
  • dyspnoea
  • overdose
  • suicide attempt
50-59:
  • pain
  • nausea
  • fall
  • diarrhoea
  • anxiety
  • pneumonia
  • hypotension
  • pyrexia
  • dehydration
  • hypoxia
60+:
  • anxiety
  • anaemia
  • confusional state
  • dyspnoea
  • pain
  • urinary tract infection
  • general physical health deterioration
  • pyrexia
  • asthenia
  • nausea

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Klonopin and Ondansetron?

Can you answer these questions?

More questions for: Klonopin, Ondansetron

You may be interested in these reviews

More reviews for: Klonopin, Ondansetron

On eHealthMe, Klonopin (clonazepam) is often used to treat stress and anxiety. Ondansetron (ondansetron) is often used to treat nausea. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.